These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11249564)

  • 1. New formulations of drugs in epilepsy.
    Wheless JW; Venkataraman V
    Expert Opin Pharmacother; 1999 Nov; 1(1):49-60. PubMed ID: 11249564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release formulations for the treatment of epilepsy.
    Bialer M
    CNS Drugs; 2007; 21(9):765-74. PubMed ID: 17696575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR).
    Stevens RE; Limsakun T; Evans G; Mason DH
    J Pharm Sci; 1998 Dec; 87(12):1531-4. PubMed ID: 10189261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily lamotrigine extended release for epilepsy management.
    Rheims S; Ryvlin P
    Expert Rev Neurother; 2009 Feb; 9(2):167-73. PubMed ID: 19210192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations.
    Garnett WR; Gilbert TD; O'Connor P
    Clin Ther; 2005 Jul; 27(7):1092-103. PubMed ID: 16154489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the pharmacotherapy of epilepsy.
    Bazil MK; Bazil CW
    Clin Ther; 1997; 19(3):369-82; discussion 367-8. PubMed ID: 9220204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Diastat, a rectal gel formulation of diazepam for acute seizure treatment.
    Pellock JM
    Drug Saf; 2004; 27(6):383-92. PubMed ID: 15144232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. The Tegretol OROS Osmotic Release Delivery System Study Group.
    Neurology; 1995 Sep; 45(9):1703-7. PubMed ID: 7675230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of new antiepileptic drugs.
    Walker MC; Patsalos PN
    Pharmacol Ther; 1995; 67(3):351-84. PubMed ID: 8577822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.
    Anderson GD; Saneto RP
    CNS Drugs; 2015 Aug; 29(8):669-81. PubMed ID: 26369919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North American Diastat Group.
    Mitchell WG; Conry JA; Crumrine PK; Kriel RL; Cereghino JJ; Groves L; Rosenfeld WE
    Epilepsia; 1999 Nov; 40(11):1610-7. PubMed ID: 10565590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.
    Patel SI; Birnbaum AK; Cloyd JC; Leppik IE
    CNS Drugs; 2015 Dec; 29(12):1009-22. PubMed ID: 26603741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of epilepsy in the new millennium.
    Pellock JM
    Pharmacotherapy; 2000 Aug; 20(8 Pt 2):129S-138S. PubMed ID: 10937812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy.
    Pellock JM; Smith MC; Cloyd JC; Uthman B; Wilder BJ
    Epilepsy Behav; 2004 Jun; 5(3):301-7. PubMed ID: 15145298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate Extended Release: A Review in Epilepsy.
    Hoy SM
    CNS Drugs; 2016 Jun; 30(6):559-66. PubMed ID: 27224993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.